ACP: Switching From Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DM
Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide
Alteplase Increases Frequency of Functional Independence After Posterior Circulation Stroke
Findings seen in patients with posterior circulation stroke and with no planned thrombectomy who received alteplase 4.5 to 24 hours after stroke onset
FDA Delays Final Approval of Novavax COVID Vaccine
Rise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to...
GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner
Zoster Vaccine Has Dementia-Preventing or Delaying Effect
Receipt of zoster vaccine reduces probability of new dementia diagnosis over seven-year period by 3.5 percentage points
Postpartum Hormonal Contraceptives Tied to Higher Depression Risk
The earlier combined oral contraceptive use is initiated, the higher the risk for depression
Two Louisiana Infants Die of Whooping Cough Amid Drop in Vaccinations
ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes
Zepbound Now Available Through Hims & Hers
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombin
